原 めぐみ はら めぐみ 先生

来歴等

略歴

2007年 佐賀大学 医学部社会医学講座予防医学分野 助教
2011年 佐賀大学 医学部社会医学講座予防医学分野 講師
2016年 佐賀大学 医学部社会医学講座予防医学分野 准教授
2025年 佐賀大学 医学部社会医学講座予防医学分野 教授

もっと見る

論文

• 1. Effectiveness of BNT162b2 Vaccine Against Symptomatic SARS-CoV-2 Infection in Children Aged 5-11 Years in Japan During Omicron Variant Predominate Periods. Journal of epidemiology. 34(5):205-210, 2024.

  Hara M, Ohta Y, Fusazaki N, Hirota Y

• 2. Comparison of self-reported symptoms in COVID-19 patients who had or had not previously received COVID-19 mRNA vaccination. Human Vaccines and Immunotherapeutics. 19(2), 2023.

  Hara M, Furue T, Fukuoka M, Iwanaga K, Matsuishi E, Miike T, Sakamoto Y, Mukai N, Kinugasa Y, Shigyo M, Sonoda N, Tanaka M, Arase Y, Tanaka Y, Nakashima H, Irie S, Hirota Y

• 3. Moderate-to-vigorous Physical Activity and Sedentary Behavior Are Independently Associated With Renal Function: A Cross-sectional Study. Journal of Epidemiology. 33(6):285-293, 2023.

  Hara M, Nishida Y, Tanaka K, Shimanoe C, Koga K, Furukawa T, Higaki Y, Shinchi K, Ikezaki H, Murata M, Takeuchi K, Tamura T, Hishida A, Tsukamoto M, Kadomatsu Y, Matsuo K, Oze I, Mikami H, Kusakabe M, Takezaki T, Ibusuki R, Suzuki S, Nakagawa-Senda H, Matsui D, Koyama T, Kuriki K, Takashima N, Nakamura Y, Arisawa K, Katsuura-Kamano S, Wakai K, for the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study

• 4. Real-World Effectiveness of the mRNA COVID-19 Vaccines in Japan: A Case–Control Study. Vaccines. 10(5), 2022.

  Hara M, Furue T, Fukuoka M, Iwanaga K, Matsuishi E, Miike T, Sakamoto Y, Mukai N, Kinugasa Y, Shigyo M, Sonoda N, Tanaka M, Arase Y, Tanaka Y, Nakashima H, Irie S, Hirota Y

• 5. Acceptance of Booster COVID-19 Vaccine and Its Association with Components of Vaccination Readiness in the General Population: A Cross-Sectional Survey for Starting Booster Dose in Japan. Vaccines. 10(7), 2022.

  Tokiya M, Hara M, Matsumoto A, Ashenagar MS, Nakano T, Hirota Y

• 6. Variant Allele of ALDH2, rs671, Associates with Attenuated Post-Vaccination Response in Anti-SARS-CoV-2 Spike Protein IgG: A Prospective Study in the Japanese General Population. Vaccines. 10(7), 2022.

  Matsumoto A, Hara M, Ashenagar MS, Tokiya M, Sawada T, Iwasaka C, Furukawa T, Kitagawa K, Miyake Y, Hirota Y

• 7. Comparison of CLEIA and ELISA for SARS-CoV-2 Virus Antibodies after First and Second Dose Vaccinations with the BNT162b2 mRNA Vaccine. Vaccines. 10(4), 2022.

  Ashenagar MS, Matsumoto A, Sakai H, Tokiya M, Hara M, Hirota Y

• 8. Problems with catch-up HPV vaccination after resumption of proactive recommendations. The Lancet Oncology. 23(8):972-973, 2022.

  Sekine M, Yamaguchi M, Kudo R, Hanley SJB, Ueda Y, Kurosawa M, Adachi S, Miyagi E, Hara M, Enomoto T

• 9. Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity. Cancer Science. 113(9):3211-3220, 2022

  Kudo R, Sekine M, Yamaguchi M, Hara M, Hanley SJB, Kurosawa M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, Enomoto T

• 10. Epigenome-Wide Association Study Identified VTI1A DNA Methylation Associated With Accelerometer-Assessed Physical Activity. Medicine and Science in Sports and Exercise. 54(11):1879-1888, 2022.

  Nishida Y, Hara M, Ohmomo H, Ono K, Shimizu A, Horita M, Shimanoe C, Taguchi N, Higaki Y, Tanaka K

• 11. Long-term effectiveness of HPV vaccination against HPV infection in young Japanese women: Real-world data. Cancer Science. 113(4):1435-1440, 2022.

  Kurosawa M, Sekine M, Yamaguchi M, Kudo R, Hanley SJB, Hara M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, Enomoto T

• 12. Sequence analysis of a feline- and porcine-origin G3P[9] rotavirus A strain in a child with acute gastroenteritis in Japan. Archives of Virology. 168(2), 2023.

  Fukuda Y, Araki K, Hara M, Yamashita Y, Adachi S, Honjo S, Togashi A, Hirakawa S, Fukumura S, Yamamoto M, Tsugawa T

• 13. Association Between the Appendicular Extracellular-to-Intracellular Water Ratio and All-Cause Mortality: A 10-Year Longitudinal Study. The journals of gerontology. Series A, Biological sciences and medical sciences. 79(2), 2024.

  Iwasaka C, Yamada Y, Nishida Y, Hara M, Yasukata J, Miyoshi N, Shimanoe C, Nanri H, Furukawa T, Koga K, Horita M, Higaki Y, Tanaka K

• 14. Association between green tea and coffee consumption and body iron storage in Japanese men and women: a cross-sectional study from the J-MICC Study Saga. Frontiers in Nutrition. 10, 2023.

  Nanri H, Hara M, Nishida Y, Shimanoe C, Iwasaka C, Higaki Y, Tanaka K

• 15. Dose-response relationship between daily step count and prevalence of sarcopenia: A cross-sectional study. Experimental Gerontology. 175, 2023.

  Iwasaka C, Yamada Y, Nishida Y, Hara M, Yasukata J, Miyoshi N, Shimanoe C, Nanri H, Furukawa T, Koga K, Horita M, Higaki Y, Tanaka K

• 16. Sedentary time, physical activity, and serum SPARC in a middle-aged population. European Journal of Sport Science. 22(11):1786-1794, 2022.

  Nishida Y, Hara M, Higaki Y, Taguchi N, Nakamura K, Nanri H, Imaizumi T, Sakamoto T, Shimanoe C, Horita M, Shinchi K, Tanaka K

• 17. Reply to the comments on “Association between habitual coffee consumption and skeletal muscle mass in middle-aged and older Japanese people”. Geriatrics and Gerontology International. 22(1):89-91, 2022.

  Iwasaka C, Yamada Y, Nishida Y, Hara M, Yasukata J, Miyoshi N, Shimanoe C, Nanri H, Furukawa T, Koga K, Horita M, Higaki Y, Tanaka K

• 18. A Nationwide Epidemiological Survey of Adolescent Patients With Diverse Symptoms Similar to Those Following Human Papillomavirus Vaccination: Background Prevalence and Incidence for Considering Vaccine Safety in Japan. Journal of Epidemiology. 32(1):34-43, 2022.

  Fukushima W, Hara M, Kitamura Y, Shibata M, Ugawa Y, Hirata K, Oka A, Miyamoto S, Kusunoki S, Kuwabara S, Hashimoto S, Sobue T

• 19. Effect of the interaction between physical activity and estimated macronutrient intake on HbA1c: population-based cross-sectional and longitudinal studies. BMJ Open Diabetes Research and Care. 10(1), 2022.

  Furukawa T, Nishida Y, Hara M, Shimanoe C, Koga K, Iwasaka C, Higaki Y, Tanaka K, Nakashima R, Ikezaki H, Hishida A, Tamura T, Kato Y, Tamada Y, Matsuo K, Ito H, Mikami H, Kusakabe M, Ibusuki R, Shibuya K, Suzuki S, Nakagawa-Senda H, Ozaki E, Matsui D, Kuriki K, Nakamura Y, Kadota A, Arisawa K, Katsuura-Kamano S, Takeuchi K, Wakai K

• 20. Long-Term Effects of Human Papillomavirus Vaccination in Clinical Trials and Real-World Data: A Systematic Review. Vaccines. 10(2), 2022.

  Kurosawa M, Sekine M, Yamaguchi M, Kudo R, Hanley SJB, Hara M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, Enomoto T

• 21. Association of Vaccine Confidence and Hesitancy in Three Phases of COVID-19 Vaccine Approval and Introduction in Japan. Vaccines. 10(3), 2022.

  Tokiya M, Hara M, Matsumoto A, Ashenagar MS, Nakano T, Hirota Y

• 22. Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women: real-world data. Lancet Regional Health - Western Pacific. 16, 2021.

  Sekine M, Yamaguchi M, Kudo R, Hanley SJB, Ueda Y, Adachi S, Kurosawa M, Miyagi E, Hara M, Enomoto T

• 23. Risk factors for HPV infection and high-grade cervical disease in sexually active Japanese women. Scientific Reports. 11(1), 2021.

  Yamaguchi M, Sekine M, Hanley SJB, Kudo R, Hara M, Adachi S, Ueda Y, Miyagi E, Enomoto T

• 24. Differences in COVID-19 vaccine acceptance, hesitancy, and confidence between healthcare workers and the general population in Japan. Vaccines. 9(12), 2021.

  Hara M, Ishibashi M, Nakane A, Nakano T, Hirota Y

• 25. Parents’ views on mumps, mumps vaccine, and the factors associated with vaccination in Japan. Vaccine. 39(52):7677-7683, 2021.

  Hara M, Koshida R, Nakano T

• 26. Association between habitual coffee consumption and skeletal muscle mass in middle-aged and older Japanese people. Geriatrics and Gerontology International. 21(10):950-958, 2021.

  Iwasaka C, Yamada Y, Nishida Y, Hara M, Yasukata J, Miyoshi N, Shimanoe C, Nanri H, Furukawa T, Koga K, Horita M, Higaki Y, Tanaka K

• 27. Effectiveness of four doses of pertussis vaccine during infancy diminished in elementary school age: A test-negative case-control study in Japan. Vaccine. 39(1):11-17, 2021.

  Ohfuji S, Okada K, Mouri Y, Mihara Y, Ishii S, Miyata A, Fujino M, Motomura C, Ito H, Ohta M, Kasahara Y, Nakamura H, Hasui M, Yoshikawa T, Tanaka T, Nakano T, Koshida R, Araki K, Hara M, Hirota Y

• 28. Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: A nationwide case-control study. Cancer Science. 112(2):839-846, 2021.

  Ikeda S, Ueda Y, Hara M, Yagi A, Kitamura T, Kitamura Y, Konishi H, Kakizoe T, Sekine M, Enomoto T, Sobue T

• 29. The interaction between mitochondrial haplogroups (M7a/D) and physical activity on adiponectin in a Japanese population. Mitochondrion. 53:234-242, 2020.

  Nishida Y, Hara M, Fuku N, Taguchi N, Horita M, Shimanoe C, Higaki Y, Tanaka K

• 30. Determinants of self-paid rotavirus vaccination status in Kanazawa, Japan, including socioeconomic factors, parents' perception, and children's characteristics. BMC Infectious Diseases. 20(1), 2020.

  Hara M, Koshida R, Araki K, Kondo M, Hirota Y

もっと見る

著書

• 1. すぐに使えるパワーポイントデータ収録 保健クイズブック．少年写真新聞社．東京 2020.

• 2. 健康クイズ100 第3章，第4章，第5章．41-86, 105-112，少年写真新聞社. 東京 2013.

もっと見る

受賞

• 2014年 資生堂 女性研究者サイエンスグラント受賞

• 2015年 日本ワクチン学会 高橋奨励賞受賞

• 2024年 佐賀大学 黒田チカ記念賞受賞

SNS・ブログ等

• その他メディア
  • 佐賀大学医学部社会医学講座予防医学分野